Thus, ACE2 overexpression in diabetic patients may possibly provide an insight into the statistically significant increased mortality in diabetics in general and in our cohort of COVID-19 patients specifically despite treatment with CCP early on in their disease. The gene discussed is ACE2; the disease is COVID-19.